UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023431
Receipt number R000026998
Scientific Title A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep: randomized, placebo-controlled, double blind traial, cross-over study
Date of disclosure of the study information 2016/08/02
Last modified on 2019/06/12 13:39:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep: randomized, placebo-controlled, double blind traial, cross-over study

Acronym

A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep

Scientific Title

A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep: randomized, placebo-controlled, double blind traial, cross-over study

Scientific Title:Acronym

A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study evaluates the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on quality of sleep, stress and mental fatigue for those who are possibly exposed to a problem with sleep, for 1 week, compared to placebo group.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measurement of EEG during sleep (Mesurement time: before and after the intake of the sample)

Key secondary outcomes

-Sleep, Stress, and Mental Fatigue: VAS
-Sleep: OSA
-Sleep: PSQI-j
(Mesurement time: before and after the intake of the sample)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food containing GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum once a day for 1 week

Interventions/Control_2

Intake of placebo without GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum once a day for 1 week

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Males and females from 20 to 65 years of age
2) PSQI-j score is 6 points or more

Key exclusion criteria

1) Subjects who routinely use food supplements or medicine containing GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum.
2) Subjects who take care for the improvement of mental fatigue, quality of sleep and stress.
3) Subjects who have been diagnosed for and who are under any medical treatment.
4) Subjects who have history of the medical treatment and who are under the medical treatment for diabetes, liver disease, kidney disease, or heart disease.
5) Subjects who are planning to become pregnant and who are lactating.
6) Subjects who are judged as unsuitable for the study by doctor for other reasons.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Horie

Organization

Pharma Foods International Co., Ltd.

Division name

Research and Development Department

Zip code


Address

1-49 Goryo-Ohara, Nishikyo-ku, Kyoto

TEL

075-394-8605

Email

k-horie@pharmafoods.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Utano Nakamura

Organization

Pharma Foods International Co., Ltd.

Division name

Research and Development Department

Zip code


Address

1-49 Goryo-Ohara, Nishikyo-ku, Kyoto

TEL

075-394-8605

Homepage URL


Email

u-nakamura@pharmafoods.co.jp


Sponsor or person

Institute

Pharma Foods International Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

FH01140020201

Org. issuing International ID_1

Nihonbashi-egawa clinical research ethical review committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社ファーマフーズ


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 06 Month 15 Day

Date of IRB

2016 Year 07 Month 15 Day

Anticipated trial start date

2016 Year 08 Month 02 Day

Last follow-up date

2017 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 01 Day

Last modified on

2019 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026998


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name